Lilly's Foundayo: New Weight-Loss Pill, Market Race
Business & Finance News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eli Lillys new weight-loss pill, Foundayo, receives FDA approval, priced at $149 per month. Launching on LillyDirect, it competes with Novo Nordisks semaglutide, with Lilly projecting $18 billion in sales by 2030. Foundayo offers eleven percent weight loss with fewer side effects than injections, potentially disrupting the $100 billion obesity market.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/626d8f6245ac1c24